Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis - PubMed (original) (raw)

. 2005 Nov;447(5):859-68.

doi: 10.1007/s00428-005-0001-8. Epub 2005 Aug 5.

Affiliations

• PMID: 16086153
• DOI: 10.1007/s00428-005-0001-8

Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis

Yasufumi Goto et al. Virchows Arch. 2005 Nov.

Abstract

Lysyl oxidase (LOX), an extracellular enzyme, plays a key role in the post-translational modification of collagens and elastin, catalyzing inter- and intra-crosslinking reactions. Because the crosslinked extracellular matrices (ECMs) are highly resistant to degradative enzymes, it is considered that the over-expression of LOX may cause severe fibrotic degeneration. In the present study, we addressed the role of LOX-mediated crosslinking in chronic renal tubulointerstitial fibrosis using an animal model of hereditary nephrotic syndrome, the Institute of Cancer Research (ICR)-derived glomerulonephritis (ICGN) mouse. Ribonuclease protection assay (RPA) revealed that LOX mRNA expression was up-regulated in the kidneys of ICGN mice as compared with control ICR mice. High-level expression of LOX and transforming growth factor (TGF)-beta1 (an up-regulator of LOX) mRNA was detected in tubular epithelial cells of ICGN mouse kidneys by in situ hybridization. Type-I and -III collagens, major substrates for LOX, were accumulated in tubulointerstitium of ICGN mouse kidneys. The present findings imply that TGF-beta1 up-regulates the production of LOX in tubular epithelial cells of ICGN mouse kidneys, and the excessive LOX acts on interstitial collagens and catalyzes crosslinking reactions. As a result, the highly crosslinked collagens induce an irreversible progression of chronic renal tubulointerstitial fibrosis in the kidneys of ICGN mice.

PubMed Disclaimer

Similar articles

• Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
  Goto Y, Manabe N, Uchio-Yamada K, Yamaguchi-Yamada M, Inoue N, Yamamoto Y, Ogura A, Nagano N, Miyamoto H. Goto Y, et al. Cell Tissue Res. 2004 Feb;315(2):209-21. doi: 10.1007/s00441-003-0824-z. Epub 2003 Nov 13. Cell Tissue Res. 2004. PMID: 14615933
• Changes in the localization of type I, III and IV collagen mRNAs in the kidneys of hereditary nephritic (ICGN) mice with renal fibrosis.
  Uchio K, Manabe N, Yamaguchi-Yamada M, Goto Y, Yamamoto Y, Ogura A, Miyamoto H. Uchio K, et al. J Vet Med Sci. 2004 Feb;66(2):123-8. doi: 10.1292/jvms.66.123. J Vet Med Sci. 2004. PMID: 15031538
• Abnormalities of extracellular matrices and transforming growth factor beta1 localization in the kidney of the hereditary nephrotic mice (ICGN strain).
  Uchio K, Manabe N, Kinoshita A, Tamura K, Miyamoto M, Ogura A, Yamamoto Y, Miyamoto H. Uchio K, et al. J Vet Med Sci. 1999 Jul;61(7):769-76. doi: 10.1292/jvms.61.769. J Vet Med Sci. 1999. PMID: 10458099
• Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects.
  López B, González A, Hermida N, Valencia F, de Teresa E, Díez J. López B, et al. Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H1-9. doi: 10.1152/ajpheart.00335.2010. Epub 2010 May 14. Am J Physiol Heart Circ Physiol. 2010. PMID: 20472764 Review.
• Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways.
  Laczko R, Csiszar K. Laczko R, et al. Biomolecules. 2020 Jul 22;10(8):1093. doi: 10.3390/biom10081093. Biomolecules. 2020. PMID: 32708046 Free PMC article. Review.

Cited by

• The myofibroblast matrix: implications for tissue repair and fibrosis.
  Klingberg F, Hinz B, White ES. Klingberg F, et al. J Pathol. 2013 Jan;229(2):298-309. doi: 10.1002/path.4104. J Pathol. 2013. PMID: 22996908 Free PMC article. Review.
• Lysyl oxidase family members in urological tumorigenesis and fibrosis.
  Li T, Wu C, Gao L, Qin F, Wei Q, Yuan J. Li T, et al. Oncotarget. 2018 Apr 13;9(28):20156-20164. doi: 10.18632/oncotarget.24948. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732010 Free PMC article. Review.
• Mechanisms for the Resolution of Organ Fibrosis.
  Horowitz JC, Thannickal VJ. Horowitz JC, et al. Physiology (Bethesda). 2019 Jan 1;34(1):43-55. doi: 10.1152/physiol.00033.2018. Physiology (Bethesda). 2019. PMID: 30540232 Free PMC article. Review.
• Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis.
  Tepus M, Tonoli E, Verderio EAM. Tepus M, et al. Front Pharmacol. 2023 Jan 12;13:1041327. doi: 10.3389/fphar.2022.1041327. eCollection 2022. Front Pharmacol. 2023. PMID: 36712680 Free PMC article. Review.
• Lysyl Oxidase and the Tumor Microenvironment.
  Wang TH, Hsia SM, Shieh TM. Wang TH, et al. Int J Mol Sci. 2016 Dec 29;18(1):62. doi: 10.3390/ijms18010062. Int J Mol Sci. 2016. PMID: 28036074 Free PMC article. Review.

References

1. 1. J Cell Biol. 1986 Sep;103(3):1121-8 - PubMed
2. 1. Am J Physiol. 1999 Jul;277(1 Pt 1):C1-9 - PubMed
3. 1. Nephron. 1997;76(2):192-200 - PubMed
4. 1. J Clin Invest. 1993 Aug;92 (2):632-7 - PubMed
5. 1. J Cell Biochem. 2003 Mar 1;88(4):660-72 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal